These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26472477)

  • 61. Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain.
    Kersten C; Cameron MG; Laird B; Mjåland S
    Br J Anaesth; 2015 Nov; 115(5):761-7. PubMed ID: 26475804
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acupuncture for neuropathic pain: A meta-analysis of randomized control trials.
    Feng Z; Cui S; Yang H; Wang Y; Zhou X; Wong J; Lai L; Yang Z; Huang B; Zheng H; Xu M
    Front Neurol; 2022; 13():1076993. PubMed ID: 36698895
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fractalkine/CX
    Silva R; Malcangio M
    Front Pain Res (Lausanne); 2021; 2():684684. PubMed ID: 35295489
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Function of Adenosine 2A Receptor in High-Fat Diet-Induced Peripheral Neuropathy.
    Li J; Liu HQ; Li XB; Yu WJ; Wang T
    J Diabetes Res; 2020; 2020():7856503. PubMed ID: 32566683
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells.
    Martin-Aragon Baudel M; Espinosa-Tanguma R; Nieves-Cintron M; Navedo MF
    Front Endocrinol (Lausanne); 2020; 11():329. PubMed ID: 32528416
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.
    Effendi WI; Nagano T; Kobayashi K; Nishimura Y
    Cells; 2020 Mar; 9(3):. PubMed ID: 32213945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of chronic neuropathic pain: purine receptor modulation.
    Jacobson KA; Giancotti LA; Lauro F; Mufti F; Salvemini D
    Pain; 2020 Jul; 161(7):1425-1441. PubMed ID: 32187120
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rat Na
    Grubinska B; Chen L; Alsaloum M; Rampal N; Matson DJ; Yang C; Taborn K; Zhang M; Youngblood B; Liu D; Galbreath E; Allred S; Lepherd M; Ferrando R; Kornecook TJ; Lehto SG; Waxman SG; Moyer BD; Dib-Hajj S; Gingras J
    Mol Pain; 2019; 15():1744806919881846. PubMed ID: 31550995
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development.
    Jacobson KA; Tosh DK; Jain S; Gao ZG
    Front Cell Neurosci; 2019; 13():124. PubMed ID: 30983976
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Covalent Inhibition in Drug Discovery.
    Ghosh AK; Samanta I; Mondal A; Liu WR
    ChemMedChem; 2019 May; 14(9):889-906. PubMed ID: 30816012
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Assessment of the Target Engagement and D-Serine Biomarker Profiles of the D-Amino Acid Oxidase Inhibitors Sodium Benzoate and PGM030756.
    Howley E; Bestwick M; Fradley R; Harrison H; Leveridge M; Okada K; Fieldhouse C; Farnaby W; Canning H; Sykes AP; Merchant K; Hazel K; Kerr C; Kinsella N; Walsh L; Livermore DG; Hoffman I; Ellery J; Mitchell P; Patel T; Carlton M; Barnes M; Miller DJ
    Neurochem Res; 2017 Nov; 42(11):3279-3288. PubMed ID: 28780732
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel sodium channel antagonists in the treatment of neuropathic pain.
    Rivara M; Zuliani V
    Expert Opin Investig Drugs; 2016; 25(2):215-26. PubMed ID: 26576738
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emerging drugs for neuropathic pain.
    Gilron I; Dickenson AH
    Expert Opin Emerg Drugs; 2014 Sep; 19(3):329-41. PubMed ID: 24793304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discontinued drugs in 2012 - 2013: hepatitis C virus infection.
    Gentile I; Buonomo AR; Zappulo E; Borgia G
    Expert Opin Investig Drugs; 2015 Feb; 24(2):239-51. PubMed ID: 25384989
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discontinued neuropathic pain therapy between 2009-2015.
    Knezevic NN; Cicmil N; Knezevic I; Candido KD
    Expert Opin Investig Drugs; 2015; 24(12):1631-46. PubMed ID: 26472477
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New investigational drugs for the treatment of neuropathic pain.
    Sałat K; Kowalczyk P; Gryzło B; Jakubowska A; Kulig K
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1093-104. PubMed ID: 24896842
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emerging drugs for diabetic peripheral neuropathy and neuropathic pain.
    Papanas N; Ziegler D
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):393-407. PubMed ID: 27813425
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.